the peptic ulcer disease in borama

Upload: mohamoud-mohamed

Post on 03-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    1/6

    THE PEPTIC ULCER DISEASE IN BORAMA

    BY MOHAMOUD MOHAMED MOHAMOUD

    REG.NO=1720

    A research report is submitted in partial fulfillment requirement

    for assignment of research methodology of medicine and

    surgery of Amoud University

    Prof. Abib adan

    Borama Somaliland

    May 2012

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    2/6

    Research assignment contents

    1: Introduction to peptic ulcer disease

    The definition of pud

    Types of pud

    2: Peptic ulcer disease in borama

    The reason of the study

    Reports of the inpatient and outpateints

    The questionnaire of dareymaane

    3: The causes of peptic ulcer disease

    4: The treatments of peptic ulcer disease

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    3/6

    1: Introduction to peptic ulcer disease

    Burning epigastric pain exacerbated by fasting and improved with meals is a symptom complex

    associated with peptic ulcer disease (PUD). An ulceris defined as disruption of the mucosal integrity of

    the stomach and/or duodenum leading to a local defect or excavation due to active inflammation.

    Ulcers occur within the stomach and/or duodenum and are often chronic in nature. Acid peptic

    disorders are very common in this region, with 80 0/0 individuals (new cases and recurrences) affected

    per year.

    PUD occurs most commonly in duodenal bulb (duodenal ulcerDU) and stomach (gastric

    ulcerGU). It may also occur in esophagus, pyloric channel, duodenal loop, jejunum, Meckels

    diverticulum. PUD results when aggressive factors (gastric acid, pepsin) overwhelm

    defensive factors involved in mucosal resistance (gastric mucus, bicarbonate,

    microcirculation, prostaglandins, mucosal barrier), and from effects ofHelicobacter pylori.

    Peptic ulcer disease is one of the common diseases in this community, and it became the most

    widespread disease that is diagnosed by many people every day. Although it is not recorded

    well the cases that encountered in the hospital, I tried to make some research that helps me

    feel the problem which faces our community when I was doing my normal duty and my

    education in the hospital. In fact it is difficult to get the correct information about this problem,

    because there is no record that I can get the former information such cases before years or

    decades so the classification of the increasing and decreasing of the disease is very difficult. But

    in my trail research, it seems that this disease increases fast as compared to other chronic

    diseases.

    This disease has major effect in this community ( especially the people who live low life but not

    always true).Although this is the normal disease of this community geographically, it may exist

    the other community outside this community. There are many things that induced me to know

    this problem such the increasing the number of people who died the outcomes or the

    consequences from it, the increasing number of the people who are suffering from it and

    complaining its troublesome effects.

    Epidemiologically this disease varies throughout the world and depends largely on the overall

    standard of living in the region. In developing parts of the world, 80% of the population may beinfected by the age of 20, whereas the prevalence is 2050% in industrialized countries. In

    contrast, in the United States this organism is rare in childhood.

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    4/6

    2: peptic ulcer disease in borama

    There are many people who have suffered from peptic ulcer disease and it became the most

    common chronic disease in this community. Although it cannot be revealed the accurate

    information of this disease by laboratories due to their fault, There are more than fivelaboratories which I have taken the following data. The first data is taken from borama general

    laboratory and its clinical diagnosis indicates that 20 0/0 outpatient had peptic ulcer disease

    while 5 0/0 had its chronic effects and the other laboratories indicates same as this one.

    Some report, which was written by some medical student, I found in the emergency office of

    the borama general hospital ,this report was collected the inpatient who was suffered by

    peptic ulcer disease and indicated that majority of the inpatients had diagnosed peptic ulcer

    disease.the patients report can found in the hospital though most of the report are not

    collected well and when the patient is either discharged or died, is discarded.

    Last month, one of the senior medical students in Amoud University took questionnaires about

    peptic ulcer disease. This questionnaire consisted of five pages and the site is dareymaane

    community sector. The people, who were questioned, are the resident of dareymaane. This

    questionnaire gave us data that indicates the incidence of the disease that we can take account

    for it. The age of the people who was questioned is about 50-68 years out of 20 persons. So

    that this disease affect the majority of the in all ages even the young adults of this town. There

    is another interesting information which reveals that this disease is endemic to this town

    because the student who came from other regions told me that when they came here they

    suffered from PUD and when they come back to their regions they felt healthy, so in case of this

    there is some etiologic factors which need scientific investigation to the fact of the causative

    things.

    In my view point, I believe that there are many things which causes this disease in this town,

    either can be life style such as food, water and importing materials such as oil or psychological

    problems like stress which is the major contributor of this disease. So I am informing the

    researchers to do this condition which is getting worse day after day.

    3: The causes of peptic ulcer disease

    Major role for H. pylori, spiral urease-producing organism that colonizes gastric antral mucosa

    in up to 100% of persons with DU and 80% with GU. Also found in normals (increasing

    prevalence with age) and those of low socioeconomic status. Invariably associated with

    histological evidence of active chronic gastritis, which over years can lead to atrophic gastritis

    and gastric cancer. Other major cause of ulcers is NSAIDs (those not due to H. pylori). Fewer

    than 1% are due to gastronome (Zollinger-Ellison syndrome). Other risk factors and

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    5/6

    associations: hereditary (? increased parietal cell number), smoking, hypercalcemia,

    mastocytosis, blood group O (antigens may bind H. pylori). Unproven: stress, coffee, alcohol.

    DUMild gastric acid hypersecretion resulting from (1) increased release of gastrin, presumably

    due to (a) stimulation of antral G cells by cytokines released by inflammatory cells and (b)

    diminished production of somatostatin by D cells, both resulting from H. pyloriinfection; and

    (2) an exaggerated acid response to gastrin due to an increased parietal cell mass resulting fromgastrin stimulation. These abnormalities reverse rapidly with eradication ofH. pylori. However,

    a mildly elevated maximum gastric acid output in response to exogenous gastrin persists in

    some pts long after eradication ofH. pylori, suggesting that gastric acid hypersecretion may be,

    in part, genetically determined. H. pylorimay also result in elevated serum pepsinogen levels.

    Mucosal defense in duodenum is compromised by toxic effects ofH. pyloriinfection on patches

    of gastric metaplasia that result from gastric acid hypersecretion or rapid gastric emptying.

    Other riskfactors include glucocorticoids, NSAIDs, chronic renal failure, renal transplantation,

    cirrhosis, chronic lung disease. GUH. pyloriis also principal cause. Gastric acid secretory rates

    usually or reduced, possibly reflecting earlier age of infection by H. pylorithan in DU pts.

    Gastritis due to reflux of duodenal contents (including bile) may play a role. Chronic salicylate or

    NSAID use may account for 1530% of GUs and increase riskof associated bleeding, perforation.

    CLINICAL FEATURES

    DUBurning epigastric pain 90 min to 3 h after meals, often nocturnal, relieved by food.

    GUBurning epigastric pain made worse by or unrelated to food; anorexia, food aversion,

    weight loss (in 40%). Great individual variation. Similar symptoms may occur in persons without

    demonstrated peptic ulcers (nonulcer dyspepsia); less responsive to standard therapy.

    COMPLICATIONS Bleeding, obstruction, penetration causing acute

    Pancreatitis, perforation, intractability.

    TREATMENTObjectives: pain relief, healing, prevention of complications, prevention of recurrences. For GU,

    exclude malignancy (follow endoscopically to healing). Dietary restriction unnecessary with

    contemporary drugs; discontinue NSAIDs; smoking may prevent healing and should be stopped.

    Eradication ofH. pylorimarkedly reduces rate of ulcer relapse and is indicated for all DUs and

    GUs associated with H. pylori(Table 150-2). Acid suppression is generally included in regimen.

    Standard drugs (H2-receptor blockers, sucralfate, antacids) heal 8090% of DUs and 60% of GUs

    in 6 weeks; healing is more rapid with omeprazole (20 mg/d).

    SurgeryFor complications (persistent or recurrent bleeding, obstruction, perforation) or, uncommonly,

    intractability (first screen for surreptitious NSAID use and gastrinoma).

    TRIPLE THERAPY dose1. Bismuth subsalicylateplus 2 tablets qidMetronidazoleplus 250 mg qid

  • 7/29/2019 The Peptic Ulcer Disease in Borama

    6/6

    Tetracyclinea 500 mg qid

    2. Ranitidine bismuth citrateplus 400 mg bid

    Tetracyclineplus 500 mg bid

    Clarithromycin ormetronidazole 500 mg bid

    3. Omeprazole (lansoprazole)plus 20 mg bid (30 mg bid)

    Clarithromycinplus 250 or 500 mg bidMetronidazoleb or 500 mg bid

    Amoxicillinc 1 g bid

    QUADRUPLE THERAPYOmeprazole (lansoprazole) 20 mg (30 mg) daily

    Bismuth subsalicylate 2 tablets qid

    Metronidazole 250 mg qid

    Tetracycline 500 mg qid

    References include:

    Borama general hospital data

    Allaale hospital data and other laboratories

    The questionnaire of senior medical students in daraymaane

    The Harrisons book

    The interview.